Comments
Loading...
Vaxcyte (NASDAQ:PCVX) Stock Quotes, Forecast and News Summary
Vaxcyte Stock (NASDAQ: PCVX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Vaxcyte (PCVX) stock?
You can purchase shares of Vaxcyte (NASDAQ:PCVX) through any online brokerage.
Who are Vaxcyte (PCVX) competitors?
Other companies in Vaxcyte’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).
What is the forecast, or price target, for Vaxcyte (PCVX) stock?
Vaxcyte has a consensus price target of $126.25.
What is the current price for Vaxcyte (PCVX)?
The stock price for Vaxcyte (NASDAQ: PCVX) is $92.16 last updated November 27, 2024 at 11:41 AM EST.
Does Vaxcyte (PCVX) pay a dividend?
There are no upcoming dividends for Vaxcyte.
When is Vaxcyte (NASDAQ:PCVX) reporting earnings?
Vaxcyte’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
Is Vaxcyte (PCVX) going to split?
There is no upcoming split for Vaxcyte.
What sector and industry does Vaxcyte (PCVX) operate in?
Vaxcyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.